|
1
|
Network GA: The global asthma report 2018. http://www.global-asthmareport.org/.
|
|
2
|
Papi A, Brightling C, Pedersen SE and Reddel HK: Asthma. Lancet. 391:783–800. 2018. View Article : Google Scholar
|
|
3
|
Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR and Kay AB: Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 326:298–304. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kidd P: Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 8:223–246. 2003.PubMed/NCBI
|
|
5
|
Olin JT and Wechsler ME: Asthma: Pathogenesis and novel drugs for treatment. BMJ. 349:pp. g55172014, View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gray LE and Sly PD: Update in asthma 2017. Am J Respir Crit Care Med. 197:1108–1115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barnig C, Frossard N and Levy BD: Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther. 186:98–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Global Initative for Asthma: GINA Report, Global strategy for asthma management and prevention (2015 update). https://ginasthma.org/gina-reports/.
|
|
9
|
Dahl R: Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 100:1307–1317. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roland NJ, Bhalla RK and Earis J: The local side effects of inhaled corticosteroids: Current understanding and review of the literature. Chest. 126:213–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Busse WW, Katial R, Gossage D, Sari S, Wang B, Kolbeck R, Coyle AJ, Koike M, Spitalny GL, Kiener PA, et al: Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol. 125:1237–1244.e2. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, et al: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 356:2144–2148. 2000. View Article : Google Scholar
|
|
13
|
Flood-Page PT, Menzies-Gow AN, Kay AB and Robinson DS: Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med. 167:199–204. 2003. View Article : Google Scholar
|
|
14
|
Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER and Costa-Lotufo LV: Overview of the therapeutic potential of piplartine (piperlongumine). Eur J Pharm Sci. 48:453–463. 2013. View Article : Google Scholar
|
|
15
|
Zou P, Xia Y, Ji J, Chen W, Zhang J, Chen X, Rajamanickam V, Chen G, Wang Z, Chen L, et al: Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Cancer Lett. 375:114–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han JG, Gupta SC, Prasad S and Aggarwal BB: Piperlongumine chemosensitizes tumor cells through interaction with cysteine 179 of IκBα kinase, leading to suppression of NF-κB-regulated gene products. Mol Cancer Ther. 13:2422–2435. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim N, Do J, Bae JS, Jin HK, Kim JH, Inn KS, Oh MS and Lee JK: Piperlongumine inhibits neuroinflammation via regulating NF-κB signaling pathways in lipopolysaccharide-stimulated BV2 microglia cells. J Pharmacol Sci. 137:195–201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee W, Yoo H, Kim JA, Lee S, Jee JG, Lee MY, Lee YM and Bae JS: Barrier protective effects of piperlonguminine in LPS-induced inflammation in vitro and in vivo. Food Chem Toxicol. 58:149–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun J, Xu P, Du X, Zhang Q and Zhu Y: Piperlongumine attenuates collagen-induced arthritis via expansion of myeloid-derived suppressor cells and inhibition of the activation of fibroblast-like synoviocytes. Mol Med Rep. 11:2689–2694. 2015. View Article : Google Scholar
|
|
20
|
Zaynagetdinov R, Ryzhov S, Goldstein AE, Yin H, Novitskiy SV, Goleniewska K, Polosukhin VV, Newcomb DC, Mitchell D, Morschl E, et al: Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. Am J Respir Cell Mol Biol. 42:564–571. 2010. View Article : Google Scholar :
|
|
21
|
Kim ST, Chun JW, Park G and Koh JW: Comparative quantification of plasma TDRD7 mRNA in cataract patients by real-time polymerase chain reaction. Korean J Ophthalmol. 28:343–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ray A and Cohn L: Altering the Th1/Th2 balance as a therapeutic strategy in asthmatic diseases. Curr Opin Investig Drugs. 1:442–448. 2000.
|
|
23
|
Ray A and Cohn L: Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation. J Clin Invest. 104:985–993. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Truyen E, Coteur L, Dilissen E, Overbergh L, Dupont LJ, Ceuppens JL and Bullens DM: Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax. 61:202–208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Steinke JW and Borish L: Th2 cytokines and asthma. Interleukin-4: Its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists Respir Res. 2:66–70. 2001.
|
|
26
|
Foster PS, Hogan SP, Ramsay AJ, Matthaei KI and Young IG: Interleukin 5 deficiency abolishes eosinophilia, airways hyper-reactivity, and lung damage in a mouse asthma model. J Exp Med. 183:195–201. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL and Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science. 282:2258–2261. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Halwani R, Al-Muhsen S and Hamid Q: Airway remodeling in asthma. Curr Opin Pharmacol. 10:236–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yao X, Wang W, Li Y, Lv Z, Guo R, Corrigan CJ, Ding G, Huang K, Sun Y and Ying S: Characteristics of IL-25 and allergen-induced airway fibrosis in a murine model of asthma. Respirology. 20:730–738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
An G, Zhang X, Wang W, Huang Q, Li Y, Shan S, Corrigan CJ, Wang W and Ying S: The effects of interleukin-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma. Immunology 2018 (Epub ahead of print).
|
|
31
|
Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC and Wasserman SI: Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 89:958–967. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ and Pavord ID: Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 354:697–708. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brown SD, Brown LA, Stephenson S, Dodds JC, Douglas SL, Qu H and Fitzpatrick AM: Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma. J Allergy Clin Immunol. 135:1651–1654. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thomas PS, Yates DH and Barnes PJ: Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med. 152:76–80. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Baeuerle PA and Baichwal VR: NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 65:111–137. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiao C and Ghosh S: NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses. Adv Exp Med Biol. 560:41–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tak PP and Firestein GS: NF-kappaB: A key role in inflammatory diseases. J Clin Invest. 107:7–11. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Caramori G, Oates T, Nicholson AG, Casolari P, Ito K, Barnes PJ, Papi A, Adcock IM and Chung KF: Activation of NF-kappaB transcription factor in asthma death. Histopathology. 54:507–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Barnes PJ and Adcock IM: NF-kappa B: A pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 18:46–50. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ and Barnes PJ: Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol. 268:C331–C338. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ray A and Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA. 91:752–756. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chauhan PS, Singh DK, Dash D and Singh R: Intranasal curcumin regulates chronic asthma in mice by modulating NF-κB activation and MAPK signaling. Phytomedicine. 51:29–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gu X, Zhang Q, Du Q, Shen H and Zhu Z: Pinocembrin attenuates allergic airway inflammation via inhibition of NF-κB pathway in mice. Int Immunopharmacol. 53:90–95. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang TY, Zhou QL, Li M and Shang YX: Shikonin alleviates allergic airway remodeling by inhibiting the ERK-NF-κB signaling pathway. Int Immunopharmacol. 48:169–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang J, Fu Y, Wei Z, He X, Shi M, Kou J, Zhou E, Liu W, Yang Z and Guo C: Anti-asthmatic activity of osthole in an ovalbumin-induced asthma murine model. Respir Physiol Neurobiol. 239:64–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li J, Luo L, Wang X, Liao B and Li G: Inhibition of NF-kappaB expression and allergen-induced airway inflammation in a mouse allergic asthma model by andrographolide. Cell Mol Immunol. 6:381–385. 2009. View Article : Google Scholar : PubMed/NCBI
|
